VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,491 | -11.2% | 225 | +30.1% | 0.00% | – |
| Q2 2023 | $2,804 | -2.6% | 173 | 0.0% | 0.00% | – |
| Q1 2023 | $2,880 | -91.8% | 173 | -97.7% | 0.00% | -100.0% |
| Q4 2021 | $35,000 | +775.0% | 7,500 | +1062.8% | 0.01% | +400.0% |
| Q3 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 645 | -20.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 809 | +25.4% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +66.7% | 645 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -40.0% | 645 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $5,000 | +25.0% | 645 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | -69.2% | 645 | -53.9% | 0.00% | -60.0% |
| Q1 2019 | $13,000 | -63.9% | 1,400 | -70.8% | 0.01% | -72.2% |
| Q4 2018 | $36,000 | – | 4,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |